Fulcrum Therapeutics Company

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.

Estimated Revenue: $1B to $10B
Funding Status: IPO
Headquarters: United States
Founded Date: 2016
Technology: Cancer
Industry: Loss of Proteostasis
Employee Number: 51-100